Merck Operating Expenses 2010-2024 | MKKGY

Merck annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Merck operating expenses for the quarter ending June 30, 2024 were $4.910B, a 3.94% increase year-over-year.
  • Merck operating expenses for the twelve months ending June 30, 2024 were $18.977B, a 0.88% increase year-over-year.
  • Merck annual operating expenses for 2023 were $18.814B, a 0.55% increase from 2022.
  • Merck annual operating expenses for 2022 were $18.71B, a 1.97% increase from 2021.
  • Merck annual operating expenses for 2021 were $18.349B, a 10.41% increase from 2020.
Merck Annual Operating Expenses
(Millions of US $)
2023 $18,814
2022 $18,710
2021 $18,349
2020 $16,619
2019 $15,716
2018 $15,483
2017 $14,470
2016 $13,879
2015 $12,208
2014 $12,946
2013 $11,845
2012 $12,385
2011 $12,244
2010 $
2009 $
Merck Quarterly Operating Expenses
(Millions of US $)
2024-06-30 $4,910
2024-03-31 $4,548
2023-12-31 $4,960
2023-09-30 $4,559
2023-06-30 $4,724
2023-03-31 $4,571
2022-12-31 $4,913
2022-09-30 $4,604
2022-06-30 $4,676
2022-03-31 $4,517
2021-12-31 $4,791
2021-09-30 $4,628
2021-06-30 $4,604
2021-03-31 $4,326
2020-12-31 $4,758
2020-09-30 $3,835
2020-06-30 $3,995
2020-03-31 $4,031
2019-12-31 $4,292
2019-09-30 $3,830
2019-06-30 $3,769
2019-03-31 $3,825
2018-12-31 $3,835
2018-09-30 $3,788
2018-06-30 $3,961
2018-03-31 $3,899
2017-12-31 $4,248
2017-09-30 $3,323
2017-06-30 $3,589
2017-03-31 $3,310
2016-12-31 $3,695
2016-09-30 $3,402
2016-06-30 $3,676
2016-03-31 $3,107
2015-12-31 $3,466
2015-09-30 $2,845
2015-06-30 $3,007
2015-03-31 $2,891
2014-12-31 $3,286
2014-09-30 $3,327
2014-06-30 $3,323
2014-03-31 $3,010
2013-12-31 $3,190
2013-09-30 $2,816
2013-06-30 $2,900
2013-03-31 $2,939
2012-12-31
2012-09-30 $2,954
2012-06-30 $3,441
2012-03-31
2011-12-31
2011-09-30
2011-06-30 $3,526
2011-03-31
2010-12-31
2010-09-30 $2,527
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00